CN111359007B

CN111359007B - Modified bacterial cellulose hydrogel dressing and preparation method thereof

Info

Publication number: CN111359007B
Application number: CN202010208455.8A
Authority: CN
Inventors: 冯文学; 李杨洪
Original assignee: Ruixi Chongqing Biotechnology Co ltd
Current assignee: Ruixi Chongqing Biotechnology Co ltd
Priority date: 2020-03-23
Filing date: 2020-03-23
Publication date: 2022-01-11
Anticipated expiration: 2040-03-23
Also published as: CN111359007A

Abstract

The invention relates to a modified bacterial cellulose hydrogel dressing and a preparation method thereof, belonging to the technical field of cosmetics. The dressing comprises, by weight, 5-10% of modified bacterial cellulose, 2-3% of toluene isocyanate activated polyethylene glycol and the balance of water. The hydrogel dressing has high water holding capacity, high crystallinity, high tension and strength, good permeability to liquid, gas and electrolyte, good compatibility with skin, no irritation, effective pain relief, bacterial infection prevention, wound exudation absorption, wound healing promotion, and skin tissue growth promotion. The hydrogel dressing can also be used as a carrier for slowly releasing medicaments for carrying various medicaments, is beneficial to skin surface administration, and promotes the healing and rehabilitation of wound surfaces. The hydrogel dressing has simple preparation process and easy operation, and is suitable for expanded production.

Description

Modified bacterial cellulose hydrogel dressing and preparation method thereof

Technical Field

The invention belongs to the technical field of cosmetics, and particularly relates to a modified bacterial cellulose hydrogel dressing and a preparation method thereof.

Background

Bacterial Cellulose (BC) is a generic term for cellulose synthesized by any one of microorganisms belonging to the genus Acetobacter (Acetobacter), Agrobacterium (Agrobacterium), Rhizobium (Rhizobium), Sarcina (Sarcina), and the like under different conditions.

The bacterial cellulose and the natural cellulose generated by plants or seaweeds have the same molecular structure unit, and the modified bacterial cellulose formed by modifying the bacterial cellulose has a plurality of unique properties, such as unique biocompatibility, biodegradability, biocompatibility, no anaphylactic reaction, higher water holding capacity, high crystallinity, good nanofiber network, higher tension and strength and the like, and particularly good mechanical toughness, so that the modified bacterial cellulose has wide application in the aspects of tissue engineering scaffolds, artificial blood vessels, artificial skin, skin injury treatment and the like.

As a wound dressing, the existing artificial skin or wound dressing has the defects of poor hemostatic effect, no moisturizing effect, easy exogenous infection during soaking, easy damage to granulation tissues during replacement, delayed wound healing and the like. Therefore, there is an urgent need for a wound dressing having good biocompatibility, biodegradability, biocompatibility and no allergic reaction, as well as high water retention and crystallinity, high tension and strength.

Disclosure of Invention

In view of the above, an object of the present invention is to provide a modified bacterial cellulose hydrogel dressing; the other purpose is to provide a modified bacterial cellulose hydrogel dressing and a preparation method thereof.

In order to achieve the purpose, the invention provides the following technical scheme:

1. the modified bacterial cellulose hydrogel dressing comprises the following components in percentage by weight: 5-10% of modified bacterial cellulose, 2-3% of toluene isocyanate activated polyethylene glycol and the balance of water.

Preferably, the hydrogel dressing further comprises 0.1-3% of an active substance.

Preferably, the active substance is at least one of alcapride, acemetacin, ampiroxicam, amfenac, ibuprofen indomethacin, etodolac, ketoprofen, zaltoprofen, diclofenac, sulindac, celecoxib, tiaprofenic acid, tenoxicam, naproxen, piroxicam, felbinac, pranoprofen, flurbiprofen, mefenamic acid, meloxicam, moxezoic acid, rofecoxib, loxoprofen, clobenzaprine or lornoxicam.

Preferably, the hydrogel dressing further comprises 6-24% of acceptable auxiliary materials in the skin external preparation.

Preferably, the auxiliary materials comprise at least one of a humectant, a solubilizer, an antioxidant, a preservative, an osmotic pressure regulator or a pH regulator; the humectant accounts for 5-10% of the total weight of the dressing, the solubilizer accounts for 1-10% of the total weight of the dressing, the antioxidant accounts for 0.1-1% of the total weight of the dressing, the preservative accounts for 0.01-1% of the total weight of the dressing, the osmotic pressure regulator accounts for 0.7-0.9% of the total weight of the dressing, and the pH regulator accounts for 0.11-0.33% of the total weight of the dressing.

Preferably, the humectant is at least one of ethanol, glycerol or propylene glycol; the solubilizer is at least one of tween-80, polyoxyethylene hydrogenated castor oil or peregal O; the antioxidant is at least one of sulfite, cysteine, di-tert-butyl hydroxy toluene or potassium sorbate; the preservative is at least one of parabens, thimerosal, chlorocresol, chlorobutanol, benzoic acid or sodium benzoate; the osmotic pressure regulator is at least one of sodium chloride or glucose; the pH regulator is phosphate buffer solution.

Preferably, the mass fraction of the disodium hydrogen phosphate in the phosphate buffer solution is 0.1-0.3%, and the mass fraction of the sodium dihydrogen phosphate is 0.01-0.03%.

Preferably, the molecular weight of the bacterial cellulose in the modified bacterial cellulose is 9000-10000.

Preferably, the modified bacterial cellulose is prepared by the following method: under the alkaline condition, isopropanol reacts with bacterial cellulose at 40-45 ℃ for 8-12h, then butyl glycidyl ether is added, the temperature is raised to 50-60 ℃, then the reaction is continued for 10-12h, the pH value is adjusted to be neutral after cooling, acetone is added to obtain precipitate, the precipitate is filtered, washed by acetone, and finally filtered, dried and ground to obtain the bacterial cellulose.

Preferably, the mass ratio of the isopropanol to the bacterial cellulose to the butyl glycidyl ether is 30-50:8-10: 6-8.

Preferably, the alkaline condition is a condition of pH 8-9.

Preferably, the drying is specifically vacuum drying at 50-55 ℃.

Preferably, the molecular weight of the polyethylene glycol in the toluene isocyanate activated polyethylene glycol is 4000-6000.

Preferably, the toluene isocyanate activated polyethylene glycol is prepared by the following method: dissolving polyethylene glycol in water, adding dibutyltin dilaurate, uniformly mixing to obtain a mixed solution, dropwise adding the mixed solution into toluene isocyanate at the temperature of 50-60 ℃ at the speed of 20-30 drops/min, and continuously reacting for 30-45min after dropwise adding is finished.

Preferably, the mass ratio of the polyethylene glycol to the dibutyltin dilaurate to the toluene isocyanate is 2-3:0.005-0.01: 0.05-0.1.

2. The preparation method of the modified bacterial cellulose hydrogel dressing comprises the following steps:

(1) adding the active substance and acceptable auxiliary materials in the skin external preparation into water, and uniformly mixing to obtain a solution A;

(2) adding the modified bacterial cellulose into the solution A obtained in the step (1) for centrifugal treatment to obtain a homogeneous suspension;

(3) and (3) adding toluene isocyanate activated polyethylene glycol into the homogeneous suspension obtained in the step (2), uniformly mixing, and reacting at 40-50 ℃ for 3-6 h.

Preferably, in the step (2), the centrifugation treatment is specifically centrifugation at 10000-.

The invention has the beneficial effects that: the hydrogel dressing has high water retention, high crystallinity, high tension and strength, good permeability to liquid, gas and electrolyte, good compatibility with skin, no irritation, effective pain relief, bacterial infection prevention, wound exudation absorption, wound healing promotion and skin tissue growth benefiting. The hydrogel dressing can also be used as a carrier for slowly releasing medicaments for carrying various medicaments, is beneficial to skin surface administration, and promotes the healing and rehabilitation of wound surfaces. Modified bacterial cellulose is butyl glycidyl ether modified bacterial cellulose in the hydrogel dressing, modification is carried out through butyl glycidyl ether, the number of hydroxyl in a bacterial cellulose structure is reduced, the water solubility of the modified bacterial cellulose is increased, toluene isocyanate activated polyethylene glycol is added simultaneously, isocyanic acid radical in the substance reacts with side hydroxyl in the modified bacterial cellulose structure, on one hand, the number of hydroxyl in the modified bacterial cellulose is further reduced, the water solubility of the modified bacterial cellulose is further increased, on the other hand, the toluene isocyanate activated polyethylene glycol is grafted to a main chain of the modified bacterial cellulose, a comb-shaped or cross-linked net-shaped structure is formed, and finally formed hydrogel dressing is more stable. The hydrogel dressing has simple preparation process and easy operation, and is suitable for expanded production.

Additional advantages, objects, and features of the invention will be set forth in part in the description which follows and in part will become apparent to those having ordinary skill in the art upon examination of the following or may be learned from practice of the invention. The objectives and other advantages of the invention may be realized and attained by the means of the instrumentalities and combinations particularly pointed out hereinafter.

Detailed Description

The embodiments of the present invention are described below with reference to specific embodiments, and other advantages and effects of the present invention will be easily understood by those skilled in the art from the disclosure of the present specification. The invention is capable of other and different embodiments and of being practiced or of being carried out in various ways, and its several details are capable of modification in various respects, all without departing from the spirit and scope of the present invention.

Example 1

The modified bacterial cellulose hydrogel dressing comprises the following components in percentage by weight: 5% of modified bacterial cellulose, 2% of toluene isocyanate activated polyethylene glycol, 0.1% of active substance (rofecoxib), 16.75% of acceptable auxiliary materials in the skin external preparation (humectant [ glycerol ] 10%, solubilizer [ tween-80 ] 5%, antioxidant [ potassium sorbate ] 0.5%, preservative [ benzoic acid ] 0.05%, osmotic pressure regulator [ sodium chloride ] 0.9%, pH regulator [ disodium hydrogen phosphate with the mass fraction of 0.1%, phosphate buffer with the mass fraction of 0.02% of sodium dihydrogen phosphate ] 0.3%), and the balance of sterile water. The hydrogel dressing is prepared by the following method:

(1) reacting isopropanol with bacterial cellulose with the molecular weight of 10000 at 45 ℃ for 8h under the condition that the pH is 8.5, adding butyl glycidyl ether, heating to 55 ℃ and continuing to react for 11h, cooling, adjusting the pH to be neutral, adding acetone to obtain a precipitate, performing suction filtration, washing with acetone, filtering, performing vacuum drying at 50 ℃, and grinding to obtain modified bacterial cellulose for later use, wherein the mass ratio of the isopropanol to the bacterial cellulose to the butyl glycidyl ether is 30:9: 7;

(2) dissolving polyethylene glycol with the molecular weight of 5000 in sterile water, adding dibutyltin dilaurate, uniformly mixing to obtain a mixed solution, dropwise adding the mixed solution into toluene isocyanate at the temperature of 60 ℃ at the speed of 25 drops/min, and continuously reacting for 40min after dropwise adding is finished to prepare toluene isocyanate activated polyethylene glycol for later use, wherein the mass ratio of the polyethylene glycol to the dibutyltin dilaurate to the toluene isocyanate is 2:0.01: 0.1;

(3) according to the weight percentage of each component in the hydrogel dressing, modified bacterial cellulose, toluene isocyanate activated polyethylene glycol, an active substance (rofecoxib), auxiliary materials (a humectant [ glycerol ], a solubilizer [ Tween-80 ], an antioxidant [ potassium sorbate ], a preservative [ benzoic acid ], an osmotic pressure regulator [ sodium chloride ], a pH regulator [ phosphate buffer ]) and sterile water which can be accepted in a skin external preparation are weighed;

(4) mixing the active substance and acceptable adjuvants in skin external preparation with sterile water to obtain solution A;

(5) adding the modified bacterial cellulose into the solution A obtained in the step (4), and centrifuging at 15000rpm for 40min to obtain a homogeneous suspension;

(6) and (3) adding toluene isocyanate activated polyethylene glycol into the homogeneous suspension obtained in the step (5), uniformly mixing, and reacting at 45 ℃ for 4.5 h.

Example 2

The modified bacterial cellulose hydrogel dressing comprises the following components in percentage by weight: 10% of modified bacterial cellulose, 3% of toluene isocyanate activated polyethylene glycol, 2% of active substance (acrylide), 11.8% of auxiliary materials acceptable in skin external preparations (humectant [ ethanol ] 8%, solubilizer [ polyoxyethylene hydrogenated castor oil ] 2%, antioxidant [ cysteine ] 0.8%, preservative [ chlorocresol ] 0.1%, osmotic pressure regulator [ glucose ] 0.8%, pH regulator [ disodium hydrogen phosphate with the mass fraction of 0.3%, phosphate buffer with the mass fraction of 0.03% of sodium dihydrogen phosphate with the mass fraction of 0.1%), and the balance of sterile water. The hydrogel dressing is prepared by the following method:

(1) reacting isopropanol with bacterial cellulose with the molecular weight of 9000 at 45 ℃ for 10 hours under the condition of pH 8, adding butyl glycidyl ether, heating to 60 ℃ and continuing to react for 10 hours, cooling, adjusting the pH to be neutral, adding acetone to obtain a precipitate, performing suction filtration, washing with acetone, filtering, performing vacuum drying at 50 ℃, and grinding to obtain modified bacterial cellulose for later use, wherein the mass ratio of the isopropanol to the bacterial cellulose to the butyl glycidyl ether is 50:8: 6;

(2) dissolving polyethylene glycol with the molecular weight of 4000 in sterile water, adding dibutyltin dilaurate, uniformly mixing to obtain a mixed solution, dropwise adding the mixed solution into toluene isocyanate at the temperature of 55 ℃ at the speed of 30 drops/min, and continuously reacting for 30min after dropwise adding to obtain toluene isocyanate activated polyethylene glycol for later use, wherein the mass ratio of the polyethylene glycol to the dibutyltin dilaurate to the toluene isocyanate is 3:0.005: 0.05;

(3) according to the weight percentage of each component in the hydrogel dressing, modified bacterial cellulose, toluene isocyanate activated polyethylene glycol, active substance (Acetali), auxiliary materials (humectant [ ethanol ], solubilizer [ polyoxyethylene hydrogenated castor oil ], antioxidant [ cysteine ], preservative [ chlorocresol ], osmotic pressure regulator [ glucose ], pH regulator [ phosphate buffer ]) and sterile water which can be accepted in the skin external preparation are weighed;

(5) adding the modified bacterial cellulose into the solution A obtained in the step (4), and centrifuging at 20000rpm for 30min to obtain a homogeneous suspension;

(6) and (3) adding toluene isocyanate activated polyethylene glycol into the homogeneous suspension obtained in the step (5), uniformly mixing, and reacting at 50 ℃ for 3 h.

Example 3

The modified bacterial cellulose hydrogel dressing comprises the following components in percentage by weight: 7% of modified bacterial cellulose, 2.5% of toluene isocyanate activated polyethylene glycol, 3% of active substances (diclofenac 1.5% and naproxen 1.5%), 16.8% of acceptable auxiliary materials in the skin external preparation (humectant [ propylene glycol ] 6%, solubilizer [ peregal O ] 9%, antioxidant [ di-tert-butyl hydroxy toluene ] 0.4%, preservative [ chlorobutanol ] 0.5%, osmotic pressure regulator [ sodium chloride ] 0.7%, pH regulator [ disodium hydrogen phosphate with the mass fraction of 0.2%, phosphate buffer solution with the mass fraction of 0.01% of sodium dihydrogen phosphate ] 0.2%), and the balance of sterile water. The hydrogel dressing is prepared by the following method:

(1) reacting isopropanol with bacterial cellulose with the molecular weight of 10000 at 40 ℃ for 12h under the condition that the pH is 9, adding butyl glycidyl ether, heating to 50 ℃ and continuing to react for 12h, cooling, adjusting the pH to be neutral, adding acetone to obtain a precipitate, performing suction filtration, washing with acetone, filtering, performing vacuum drying at 55 ℃, and grinding to obtain modified bacterial cellulose for later use, wherein the mass ratio of the isopropanol to the bacterial cellulose to the butyl glycidyl ether is 40:10: 8;

(2) dissolving polyethylene glycol with molecular weight of 6000 in sterile water, adding dibutyltin dilaurate, uniformly mixing to obtain a mixed solution, dropwise adding the mixed solution into toluene isocyanate at the temperature of 50 ℃ at the speed of 20 drops/min, and continuously reacting for 45min after dropwise adding is finished to prepare toluene isocyanate activated polyethylene glycol for later use, wherein the mass ratio of the polyethylene glycol to the dibutyltin dilaurate to the toluene isocyanate is 2.5:0.006: 0.07;

(3) according to the weight percentage of each component in the hydrogel dressing, modified bacterial cellulose, toluene isocyanate activated polyethylene glycol, active substances (diclofenac acid and naproxen), auxiliary materials (a humectant [ propylene glycol ], a solubilizer [ peregal O ], an antioxidant [ di-tert-butyl hydroxy toluene ], a preservative [ chlorobutanol ], an osmotic pressure regulator [ sodium chloride ], a pH regulator [ phosphate buffer ]) and sterile water which can be accepted in the skin external preparation are weighed;

(5) adding the modified bacterial cellulose into the solution A obtained in the step (4), and centrifuging for 35min at 10000rpm to obtain a homogeneous suspension;

(6) and (3) adding toluene isocyanate activated polyethylene glycol into the homogeneous suspension obtained in the step (5), uniformly mixing, and reacting at 40 ℃ for 6 hours.

Comparative example 1

The difference from example 1 is that bacterial cellulose having a molecular weight of 10000 was not modified, and a hydrogel dressing was directly prepared using it as one of the raw materials.

Comparative example 2

The difference from example 1 is that no active substance is added.

Example 4

Mechanical property test

Tensile testing was performed on an Instron apparatus to evaluate the mechanical strength of the film. In the tensile test, both ends of a film to be measured (0.5 cm. times.3 cm, thickness 2mm) were clamped to upper and lower clamps, respectively, at a distance of 3cm, and the upper clamp was moved upward with different tensile forces.

The mechanical properties of the films were evaluated in this experiment by the degree of stretching, which is the length of the film just after it had been stretch broken at a certain tension (1, 2N). The hydrogel dressings prepared in examples 1 to 3 and comparative example 1 were subjected to a tensile test, and the test data are shown in table 1.

Table 1 hydrogel dressings prepared in examples 1 to 3 and comparative example 1 test results for degree of stretching

As can be seen from table 1, the hydrogel dressings prepared in examples 1 to 3 exhibited higher elongation than the hydrogel dressing prepared in comparative example 1.

Example 5

Water vapor transmission rate test

The hydrogel dressings prepared in examples 1 to 3 and comparative example 1 were respectively fixed on a bottle mouth (diameter: 14mm) containing 10mL of deionized water, placed in an environment maintaining a certain humidity, and tested for water vapor transmission rate, and the test results are shown in table 2.

The water vapor transmission rate was calculated by measuring the change in mass of the deionized water, and the total weight of the deionized water and the bottle was weighed at intervals.

In the formula: WVTR unit is g/m²A is the area of the mouth (m)²)，W_bThe total weight of the bottle and the deionized water before the measurement is carried out; w_tIs the total weight of the vial and deionized water after a time interval.

Table 2 test results of water vapor transmission rate of hydrogel dressing prepared in examples 1 to 3 and comparative example 1

As can be seen from table 2, the hydrogel dressings prepared in examples 1 to 3 have suitable water vapor transmission rate compared with the hydrogel dressing prepared in comparative example 1, and can prevent the accumulation of wound fluid under the dressing, and simultaneously ensure that the wound surface is maintained in a desirable moisture environment, thereby promoting the healing of the wound.

Example 6

Swelling Performance test

A crystalline region and an amorphous region exist in the supermolecular structure of the gel, and macromolecules in the crystalline region are closely arranged, and pores are small and few; the amorphous region has loose molecular arrangement and more micro-gap distribution. When the gel is contacted with water or water vapor, water molecules enter the amorphous region along the microgaps of the gel, so that the acting force among the macromolecules of the gel is weakened, the distance among the molecules is increased, the pores are enlarged, and the gel swells. The larger the swelling ratio, the larger the molecular space for water to enter the network; the smaller the swelling ratio, the smaller the molecular space for water to enter the network.

The swelling ratios of the hydrogel dressings prepared in examples 1 to 3 and comparative example 1 at different temperatures (from 12 to 60 ℃) in distilled water were measured by a gravimetric method. During testing, each hydrogel dressing was soaked in water at a certain temperature for 24h, then quickly taken out of the water, and weighed after removing the water on the surface with filter paper, to obtain the equilibrium swelling mass of the sample, and the test results are shown in table 3. The Equilibrium Swelling Ratio (ESR) of the hydrogel was calculated by the following formula,

in the formula, W_sIs the weight (g) of the hydrogel after swelling equilibrium; w_dGel dry weight (g).

Table 3 hydrogel dressing swelling property test results prepared in examples 1 to 3 and comparative example 1

As can be seen from table 3, the hydrogel dressings prepared in examples 1 to 3 were able to swell up to 7 times the original mass, had good gel stability, were able to absorb excess body fluid from the wound, did not dissolve and did not disperse after absorption, and were suitable for use as wound dressing materials.

Example 7

Test of antibacterial Property

The method comprises the following steps of selecting staphylococcus aureus and escherichia coli as test strains, respectively testing the antibacterial effect of the hydrogel dressings prepared in the embodiment 1 and the comparative embodiment 2 by adopting an agar plate diffusion method, respectively placing the two hydrogel dressings in the center of an agar culture medium coated with bacterial liquid, culturing for 24 hours in a constant-temperature incubator at 37 ℃, measuring the outer diameter width of an antibacterial band, and obtaining a test result shown in a table 4, wherein the calculation of the width (H) of the antibacterial band is shown in a formula (4):

in the formula: d is the average value (mm) of the outer diameter of the antibacterial zone; d is the diameter (mm) of the hydrogel.

Table 4 test results of antibacterial properties of hydrogel dressings prepared in example 1 and comparative example 2

As can be seen from table 4, the hydrogel dressing prepared in example 1 has a larger antibacterial ring than the hydrogel dressing prepared in comparative example 2, and has more excellent antibacterial activity and antibacterial durability.

Finally, the above embodiments are only intended to illustrate the technical solutions of the present invention and not to limit the present invention, and although the present invention has been described in detail with reference to the preferred embodiments, it will be understood by those skilled in the art that modifications or equivalent substitutions may be made on the technical solutions of the present invention without departing from the spirit and scope of the technical solutions, and all of them should be covered by the claims of the present invention.

Claims

1. The modified bacterial cellulose hydrogel dressing is characterized by comprising the following components in percentage by weight: 5-10% of modified bacterial cellulose, 2-3% of toluene isocyanate activated polyethylene glycol and the balance of water; the modified bacterial cellulose is prepared by the following method: under the alkaline condition, isopropanol reacts with bacterial cellulose at 40-45 ℃ for 8-12h, then butyl glycidyl ether is added, the temperature is raised to 50-60 ℃, then the reaction is continued for 10-12h, the pH value is adjusted to be neutral after cooling, acetone is added to obtain precipitate, the precipitate is filtered, washed by acetone, and finally filtered, dried and ground to obtain the bacterial cellulose.

2. The modified bacterial cellulose hydrogel dressing of claim 1, wherein the hydrogel dressing further comprises 0.1-3% active substance.

3. The modified bacterial cellulose hydrogel dressing of claim 2, wherein said active agent is at least one of aclopril, acemetacin, ampiroxicam, amfenac, ibuprofen indomethacin, etodolac, ketoprofen, zaltoprofen, diclofenac, sulindac, celecoxib, tiaprofenic acid, tenoxicam, naproxen, piroxicam, felbinac, pranoprofen, flurbiprofen, mefenamic acid, meloxicam, moxifloxacin, rofecoxib, loxoprofen, clobenzaprine, or lornoxicam.

4. The modified bacterial cellulose hydrogel dressing of claim 2, wherein the hydrogel dressing further comprises 6-24% of acceptable adjuvants in a skin external preparation.

5. The modified bacterial cellulose hydrogel dressing of claim 4, wherein the adjuvant comprises at least one of a humectant, a solubilizer, an antioxidant, a preservative, an osmotic pressure regulator, or a pH regulator; the humectant accounts for 5-10% of the total weight of the dressing, the solubilizer accounts for 1-10% of the total weight of the dressing, the antioxidant accounts for 0.1-1% of the total weight of the dressing, the preservative accounts for 0.01-1% of the total weight of the dressing, the osmotic pressure regulator accounts for 0.7-0.9% of the total weight of the dressing, and the pH regulator accounts for 0.11-0.33% of the total weight of the dressing.

6. The modified bacterial cellulose hydrogel dressing as claimed in any one of claims 1 to 5, wherein the molecular weight of the bacterial cellulose in the modified bacterial cellulose is 9000-10000.

7. The modified bacterial cellulose hydrogel dressing of any one of claims 1-5, wherein the molecular weight of the polyethylene glycol in the toluene isocyanate activated polyethylene glycol is 4000-6000.

8. The modified bacterial cellulose hydrogel dressing of any one of claims 1-5, wherein said toluene isocyanate activated polyethylene glycol is prepared by the following method: dissolving polyethylene glycol in water, adding dibutyltin dilaurate, uniformly mixing to obtain a mixed solution, dropwise adding the mixed solution into toluene isocyanate at the temperature of 50-60 ℃ at the speed of 20-30 drops/min, and continuously reacting for 30-45min after dropwise adding is finished.

9. The method for preparing a modified bacterial cellulose hydrogel dressing according to any one of claims 1 to 8, wherein the method comprises the following steps: